BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Teneligliptin
1
Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies
11/18/2024 3:30:39 AM | Browse: 103 | Download: 492
2
Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy
9/26/2024 8:51:01 AM | Browse: 117 | Download: 721
3
Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?
8/27/2024 3:11:19 PM | Browse: 131 | Download: 657
4
Teneligliptin: A potential therapeutic approach for diabetic cardiomyopathy
7/26/2024 6:56:09 AM | Browse: 162 | Download: 689
5
Diabetic cardiomyopathy: Emerging therapeutic options
7/26/2024 6:56:09 AM | Browse: 169 | Download: 498
6
Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
4/12/2024 1:04:39 AM | Browse: 131 | Download: 1150
7
Drug interactions of dipeptidyl peptidase 4 inhibitors involving CYP enzymes and P-gp efflux pump
4/30/2019 3:02:03 AM | Browse: 1119 | Download: 1669
8
Dipeptidyl peptidase-4: A key player in chronic liver disease
9/16/2014 1:19:00 PM | Browse: 1534 | Download: 1613
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345